Business FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea Finance News Dec 21, 2024 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March… Read More...
Business Eli Lilly weight loss drug Zepbound no longer in shortage Finance News Dec 19, 2024 An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan… Read More...
Business What Trump’s health pick RFK Jr. could mean for patients, drugmakers Finance News Nov 5, 2024 Robert F. Kennedy Jr. and Republican presidential nominee and former U.S. President Donald Trump attend a campaign… Read More...
Business Novo Nordisk’s Ozempic, Wegovy now available after shortages Finance News Oct 30, 2024 Weight loss syringes of the brands "Wegovy", "Ozempic" and "Mounjaro" are sold at In der Achat Apotheke in Mitte,… Read More...
Business McDonald’s E. coli outbreak: CDC updates case count Finance News Oct 27, 2024 A deadly E. coli outbreak linked to McDonald's Quarter Pounders has led to 75 cases in 13 states, the Centers for… Read More...
Business Trump, Harris plans on drug costs, abortion, Obamacare differ Finance News Oct 20, 2024 President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential… Read More...
Politics Novo and Lilly contender Zealand Pharma targets ‘next generation’ of Finance News Oct 11, 2024 Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a… Read More...
Politics CVS, UnitedHealth, Cigna say FTC should take Lina Khan off PBM case Finance News Oct 9, 2024 FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General… Read More...
Business CVS is considering a break up. Here’s why that could be risky Finance News Oct 6, 2024 A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty ImagesIt's time for… Read More...
Politics Novo Nordisk CEO testifies at Senate over weight loss drug prices Finance News Sep 24, 2024 Novo Nordisk's top executive faces a Senate grilling on Tuesday over the high prices of the company's weight loss… Read More...